Orchard Therapeutics
Orchard was founded in 2015—but our roots run deeper, going back to some of the first research and clinical development involving hematopoietic stem cell, or HSC, gene therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potentially life-transforming reality. Today, we carry forward our history of visionary science to imagine new possibilities for people and families affected by genetic and other severe diseases.
Basic Information
- Category: Rare Disease
- Founded: 2015
- Headquarters: London, UK
- Website: orchard-tx.com
Documented Facts
- Email: info@orchard-tx.com (No linked source recorded for this statement.)
- Founded: 2015 (No linked source recorded for this statement.)
Evidence and Sources
- Orchard Therapeutics — Official Site (official)
- Orchard Therapeutics on linkedin (social)
Citation Guidance
Explore Rare Disease profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Orchard Therapeutics.
- Canonical profile: https://brandsource.ai/brands/orchard-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/orchard-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/orchard-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (84/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T20:51:26.384Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Orchard was founded in 2015—but our roots run deeper, going back to some of the first research and clinical development involving hematopoietic stem cell, or HSC, gene therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potentially life-transforming reality. Today, we carry forward our history of visionary science to imagine new possibilities for people and families affected by genetic and other severe diseases.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.